Indian Express
Thursday, April 10, 2014
Even as Sun Pharma MD Dilip Shanghvi has stated for the record that the company is yet to take a final call on the fate of brand Ranbaxy post its $3.2 billion acquisition deal, the street view is that it could well be the end of the road for the half-a-century old brand....